A New Crystal Form of the SARS-CoV-2 Receptor Binding Domain: CR3022 Complex-An Ideal Target for In-Crystal Fragment Screening of the ACE2 Binding Site Surface. (2020)

First Author: Nichols C
Attributed to:  King’s College London Confidence in Concept 2017 funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2020.615211

PubMed Identifier: 33381049

Publication URI: http://europepmc.org/abstract/MED/33381049

Type: Journal Article/Review

Volume: 11

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812